<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-86029" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Drusen Bodies</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>VanDenLangenberg</surname>
            <given-names>Adam M.</given-names>
          </name>
          <aff>Louisiana State University Health Shreveport School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Carson</surname>
            <given-names>Michael P.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Adam VanDenLangenberg declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Carson declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-86029.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">Drusen bodies are extracellular deposits of lipids, proteins, and cellular debris which are found within the layers of the retina and appear as small, yellow deposits on dilated eye exams. Specifically, drusen reside between the basal lamina of the retinal pigment epithelium (RPE) and the inner layer of the Bruch membrane (BM). These sub-RPE deposits are seen with the progression of normal aging; however, depending on the size, number, location, and type of drusen involved, they can be associated with increased risk of developing age-related macular degeneration (AMD).<xref ref-type="bibr" rid="article-86029.r1">[1]</xref><xref ref-type="bibr" rid="article-86029.r2">[2]</xref></p>
        <p>Although there is speculation regarding the exact mechanisms involved in the formation of drusen bodies, there is a general consensus that deposits are lipid and protein-rich and are driven by age-related biochemical changes. Current evidence suggests that drusen bodies are composed of cholesterol-containing lipid droplets forming the core structure upon which hydroxyapatite (HAP) spherules precipitate. These HAP spherules facilitate protein deposition to their surface which results in an oligomerization process ultimately forming the sub-RPE deposits. One focus of the study has been the proteins involved in the formation of drusen, and many different proteins have been implicated in this process. Some of the most common proteins involved include amyloid-beta, apolipoproteins, vitronectin, and complement proteins.<xref ref-type="bibr" rid="article-86029.r2">[2]</xref><xref ref-type="bibr" rid="article-86029.r3">[3]</xref><xref ref-type="bibr" rid="article-86029.r4">[4]</xref></p>
      </sec>
      <sec id="article-86029.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>While drusen bodies are a common finding upon standard ophthalmic exams in the aging population, they are of most concern as early signs of AMD. AMD is one of the most prevalent eye diseases in the world affecting roughly 1% to 3% of the total population.<xref ref-type="bibr" rid="article-86029.r1">[1]</xref> AMD is a progressive disease involving degeneration and atrophy of the portion of the retina termed the macula. This results in progressive loss of central vision and can eventually advance to blindness. Drusen bodies are classic findings in AMD, however, certain factors such as the type, number, and location of drusen bodies have prognostic value.&#x000a0;</p>
        <p>
<bold>Types of Drusen</bold>
</p>
        <p>There are various types of drusen bodies, each of which is associated with a different prognostic value. The types of drusen are based on the size, consistency, and histological features present. Hard drusen, also termed &#x0201c;small drusen&#x0201d; are defined as small, round, well-defined deposits with a diameter measuring less than 63 microns. Hard drusen are common and are the only type of drusen considered as normal age-associated findings.<xref ref-type="bibr" rid="article-86029.r5">[5]</xref> A few small drusen noted on an exam is not alarming, however, there is some thought that these drusen have the potential to enlarge and develop more worrisome characteristics as time progresses. Intermediate drusen are&#x000a0;the hybrid form of drusen defined as a diameter between 63 microns to 125 microns. These larger drusen tend to be classified within the soft drusen category. Soft drusen are defined as larger, poorly-defined drusen with mound-like elevations and a diameter measuring greater than 125 microns.<xref ref-type="bibr" rid="article-86029.r2">[2]</xref> It is believed that larger drusen bodies contribute to the impediment of the exchange of nutrients and waste products between the choroidal blood vessels and the retina.<xref ref-type="bibr" rid="article-86029.r4">[4]</xref> The lack of metabolic exchange eventually leads to degeneration and atrophy of the retina which is the pathological process seen in AMD. Cuticular drusen are&#x000a0;defined as small, dot-like drusen which measure between 25 microns to 75 microns. Cuticular drusen are numerous and often aggregate. Therefore, they tend to&#x000a0;coalesce&#x000a0;into larger drusen deposits and can carry a significant risk of AMD.<xref ref-type="bibr" rid="article-86029.r5">[5]</xref></p>
        <p>
<bold>Number of Drusen</bold>
</p>
        <p>The smaller the number of drusen present, the lower the risk of progression to AMD. Just as an increase in the size of drusen increases the likelihood of progression to AMD, an increase in the number of drusen increases the likelihood of progression to AMD.<xref ref-type="bibr" rid="article-86029.r2">[2]</xref></p>
        <p>
<bold>Location of Drusen</bold>
</p>
        <p>Drusen bodies located on the peripheral retina are less concerning than drusen bodies located within the macula or central region of the retina. Within the macula, an area called the fovea exists which is where the highest visual acuity originates. Hard drusen are typically widespread so they can be found within the peripheral or the central retina. The same can be said for cuticular drusen. Soft drusen tend to be located more within the central retina or macula which may contribute to the fact that soft drusen have a higher likelihood of progressing to AMD.<xref ref-type="bibr" rid="article-86029.r5">[5]</xref></p>
      </sec>
      <sec id="article-86029.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Drusen bodies are a common clinical finding on an ophthalmologist&#x02019;s fundoscopic exam with hard drusen being the most abundant. According to the Beaver Dam Eye Study, hard drusen had a prevalence of 93.6% in study participants between 43 to 86 years of age.<xref ref-type="bibr" rid="article-86029.r6">[6]</xref><xref ref-type="bibr" rid="article-86029.r7">[7]</xref> While some drusen formation appears to be a consequence of biochemical changes seen with aging, the clinical significance can be defined through statistical data on the five-year rate of progression to advanced AMD categorized by drusen type. Hard, small drusen without pigmentary changes have a 0.4% five-year progression rate to advanced AMD. Intermediate drusen present in one eye without pigmentary changes have a 0.5% progression rate; while intermediate drusen present in both eyes have a 2.1% five-year progression rate. Soft, large drusen present in one eye without pigmentary changes have a 3.9% progression rate; while large drusen present in both eyes have a 13% five-year progression rate. It should be noted that the presence of pigmentary changes in one or both eyes in addition to drusen bodies significantly increases the five-year progression rate of each category of drusen.<xref ref-type="bibr" rid="article-86029.r8">[8]</xref></p>
        <p>Although drusen bodies are most commonly described in AMD, it is important to note that they are not pathognomonic of AMD. Drusen-like deposits can also be seen in some less prevalent inherited conditions such as Sorsby fundus dystrophy, North Carolina macular dystrophy, Stargardt disease, and Adult-onset foveomacular vitelliform dystrophy, just to name a few.<xref ref-type="bibr" rid="article-86029.r9">[9]</xref> Drusen deposits have also been noted in some systemic conditions such as dense deposit disease and Alport syndrome.<xref ref-type="bibr" rid="article-86029.r5">[5]</xref></p>
      </sec>
      <sec id="article-86029.s4" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>While an ophthalmologist is almost always responsible for detecting drusen bodies on fundoscopic examinations, there are other roles to play in possibly preventing progression to AMD. Extensive studies on the modifiable and unmodifiable risk factors for the progression of drusen deposits to AMD are currently ongoing. Increasing age seems to be the most consistent unmodifiable risk factor for progression to AMD; however, female sex, Caucasian race, and certain genetic markers have a higher risk for AMD.<xref ref-type="bibr" rid="article-86029.r1">[1]</xref><xref ref-type="bibr" rid="article-86029.r5">[5]</xref> Certain modifiable risk factors such as smoking, obesity, and increased sunlight exposure have been implicated to increase the risk of AMD in some studies. Whereas increased physical activity and a Mediterranean-based diet rich in antioxidants may provide protective benefits&#x000a0;against AMD according to some studies. A relationship between AMD and comorbidities such as hypertension, diabetes, chronic kidney disease, and&#x000a0;cataracts has been suggested; however, it remains unclear at this point.<xref ref-type="bibr" rid="article-86029.r1">[1]</xref></p>
        <p>Primary care physicians, nurse practitioners, and other members of an interprofessional team play a vital role in the recognition and prevention of AMD. The United States Preventive Services Task Force (USPSTF) concludes that there is insufficient evidence to make a recommendation on screening for visual acuity in elderly adults with grade I evidence.<xref ref-type="bibr" rid="article-86029.r10">[10]</xref> The American Academy of Ophthalmology (AAO) recommends that all patients age sixty-five and older receive comprehensive eye exams every one to two years regardless of a prior history of eye conditions.<xref ref-type="bibr" rid="article-86029.r11">[11]</xref>&#x000a0;Therefore, primary care providers should be aware of the risk factors and symptoms of AMD. Common visual complaints seen in AMD include blurring of central vision, a blind spot in the central vision known as a central scotoma, or lines that appear wavy which is known as metamorphopsia.<xref ref-type="bibr" rid="article-86029.r12">[12]</xref>&#x000a0;Patients presenting with these complaints should be referred to an ophthalmologist for further evaluation. Additionally, providers should also counsel patients on modifiable risk factors and encourage strategies such as smoking cessation, maintaining a healthy diet, and wearing sunglasses outdoors to protect from ultraviolet eye damage.<xref ref-type="bibr" rid="article-86029.r13">[13]</xref></p>
      </sec>
      <sec id="article-86029.s5" sec-type="Nursing, Allied Health, and Interprofessional Team Monitoring">
        <title>Nursing, Allied Health, and Interprofessional Team Monitoring</title>
        <p>One important aspect of achieving high-quality eye care for patients is an interprofessional team working towards a common goal. A team includes physicians, nurses, assistants, medical technicians, front office staff, and many others who work in unity to provide individualized care to each patient. Each member of the interprofessional team should be appropriately trained and should work in accordance with their skill level in a professional manner putting patient care above all else.<xref ref-type="bibr" rid="article-86029.r14">[14]</xref></p>
      </sec>
      <sec id="article-86029.s6">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=86029&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=86029">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/86029/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=86029">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-86029.s7">
        <title>References</title>
        <ref id="article-86029.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heesterbeek</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Lor&#x000e9;s-Motta</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hoyng</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Lechanteur</surname>
                <given-names>YTE</given-names>
              </name>
              <name>
                <surname>den Hollander</surname>
                <given-names>AI</given-names>
              </name>
            </person-group>
            <article-title>Risk factors for progression of age-related macular degeneration.</article-title>
            <source>Ophthalmic Physiol Opt</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>140</fpage>
            <page-range>140-170</page-range>
            <pub-id pub-id-type="pmid">32100327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-86029.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bergen</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Arya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Koster</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pilgrim</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Wiatrek-Moumoulidis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>van der Spek</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Hauck</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Boon</surname>
                <given-names>CJF</given-names>
              </name>
              <name>
                <surname>Emri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Lengyel</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>On the origin of proteins in human drusen: The meet, greet and stick hypothesis.</article-title>
            <source>Prog Retin Eye Res</source>
            <year>2019</year>
            <month>May</month>
            <volume>70</volume>
            <fpage>55</fpage>
            <page-range>55-84</page-range>
            <pub-id pub-id-type="pmid">30572124</pub-id>
          </element-citation>
        </ref>
        <ref id="article-86029.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brown</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>den Hollander</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Lengyel</surname>
                <given-names>I</given-names>
              </name>
              <collab>EYE-RISK consortium</collab>
            </person-group>
            <article-title>Metabolomics and Age-Related Macular Degeneration.</article-title>
            <source>Metabolites</source>
            <year>2018</year>
            <month>Dec</month>
            <day>27</day>
            <volume>9</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">30591665</pub-id>
          </element-citation>
        </ref>
        <ref id="article-86029.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rajapakse</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lerner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Campos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wistow</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Amelotin is expressed in retinal pigment epithelium and localizes to hydroxyapatite deposits in dry age-related macular degeneration.</article-title>
            <source>Transl Res</source>
            <year>2020</year>
            <month>May</month>
            <volume>219</volume>
            <fpage>45</fpage>
            <page-range>45-62</page-range>
            <pub-id pub-id-type="pmid">32160961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-86029.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khan</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Mahroo</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Mohamed</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>McKibbin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bird</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Michaelides</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tufail</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Differentiating drusen: Drusen and drusen-like appearances associated with ageing, age-related macular degeneration, inherited eye disease and other pathological processes.</article-title>
            <source>Prog Retin Eye Res</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>53</volume>
            <fpage>70</fpage>
            <page-range>70-106</page-range>
            <pub-id pub-id-type="pmid">27173377</pub-id>
          </element-citation>
        </ref>
        <ref id="article-86029.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>BEK</given-names>
              </name>
              <name>
                <surname>Linton</surname>
                <given-names>KLP</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of Age-related Maculopathy: The Beaver Dam Eye Study.</article-title>
            <source>Ophthalmology</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>127</volume>
            <issue>4S</issue>
            <fpage>S122</fpage>
            <page-range>S122-S132</page-range>
            <pub-id pub-id-type="pmid">32200811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-86029.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rudolf</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Chimento</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Medeiros</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Curcio</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>49</volume>
            <issue>3</issue>
            <fpage>1200</fpage>
            <page-range>1200-9</page-range>
            <pub-id pub-id-type="pmid">18326750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-86029.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferris</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Bird</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chakravarthy</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Chew</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Csaky</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sadda</surname>
                <given-names>SR</given-names>
              </name>
              <collab>Beckman Initiative for Macular Research Classification Committee</collab>
            </person-group>
            <article-title>Clinical classification of age-related macular degeneration.</article-title>
            <source>Ophthalmology</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>120</volume>
            <issue>4</issue>
            <fpage>844</fpage>
            <page-range>844-51</page-range>
            <pub-id pub-id-type="pmid">23332590</pub-id>
          </element-citation>
        </ref>
        <ref id="article-86029.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saksens</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Fleckenstein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schmitz-Valckenberg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Holz</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>den Hollander</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Keunen</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Boon</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Hoyng</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Macular dystrophies mimicking age-related macular degeneration.</article-title>
            <source>Prog Retin Eye Res</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>39</volume>
            <fpage>23</fpage>
            <page-range>23-57</page-range>
            <pub-id pub-id-type="pmid">24291520</pub-id>
          </element-citation>
        </ref>
        <ref id="article-86029.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <article-title>Screening for Impaired Visual Acuity in Older Adults: Recommendation Statement.</article-title>
            <source>Am Fam Physician</source>
            <year>2016</year>
            <month>Jun</month>
            <day>15</day>
            <volume>93</volume>
            <issue>12</issue>
            <fpage>Online</fpage>
            <pub-id pub-id-type="pmid">27304779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-86029.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pelletier</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Rojas-Roldan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Coffin</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Vision Loss in Older Adults.</article-title>
            <source>Am Fam Physician</source>
            <year>2016</year>
            <month>Aug</month>
            <day>01</day>
            <volume>94</volume>
            <issue>3</issue>
            <fpage>219</fpage>
            <page-range>219-26</page-range>
            <pub-id pub-id-type="pmid">27479624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-86029.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garc&#x000ed;a-Layana</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cabrera-L&#x000f3;pez</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Arum&#x000ed;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Arias-Barquet</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ruiz-Moreno</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Early and intermediate age-related macular degeneration: update and clinical review.</article-title>
            <source>Clin Interv Aging</source>
            <year>2017</year>
            <volume>12</volume>
            <fpage>1579</fpage>
            <page-range>1579-1587</page-range>
            <pub-id pub-id-type="pmid">29042759</pub-id>
          </element-citation>
        </ref>
        <ref id="article-86029.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehta</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Age-Related Macular Degeneration.</article-title>
            <source>Prim Care</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>42</volume>
            <issue>3</issue>
            <fpage>377</fpage>
            <page-range>377-91</page-range>
            <pub-id pub-id-type="pmid">26319344</pub-id>
          </element-citation>
        </ref>
        <ref id="article-86029.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nelluri</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Training the eye care team: principles and practice.</article-title>
            <source>Middle East Afr J Ophthalmol</source>
            <year>2014</year>
            <season>Apr-Jun</season>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>128</fpage>
            <page-range>128-33</page-range>
            <pub-id pub-id-type="pmid">24791103</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
